Literature DB >> 21364110

Hypertrophic obstructive cardiomyopathy, acquired von Willebrand syndrome, and gastrointestinal bleeding.

Rajiv K Pruthi.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21364110      PMCID： PMC3046936          DOI： 10.4065/mcp.2011.0023

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN： 0025-6196            Impact factor:   7.616


× No keyword cloud information.
  15 in total

Review 1.  Cell biology of von Willebrand factor.

Authors:  D D Wagner
Journal:  Annu Rev Cell Biol       Date:  1990

2.  Functional impairment of von Willebrand factor in hypertrophic cardiomyopathy: relation to rest and exercise obstruction.

Authors:  Thierry Le Tourneau; Sophie Susen; Claudine Caron; Alain Millaire; Sylvestre Maréchaux; Anne-Sophie Polge; André Vincentelli; Frederic Mouquet; Pierre-Vladimir Ennezat; Nicolas Lamblin; Pascal de Groote; Eric Van Belle; Ghislaine Deklunder; Jenny Goudemand; Christophe Bauters; Brigitte Jude
Journal:  Circulation       Date:  2008-09-22       Impact factor: 29.690

3.  Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura.

Authors:  X Zheng; D Chung; T K Takayama; E M Majerus; J E Sadler; K Fujikawa
Journal:  J Biol Chem       Date:  2001-09-13       Impact factor: 5.157

Review 4.  Acquired von Willebrand syndrome: features and management.

Authors:  Hiroshi Mohri
Journal:  Am J Hematol       Date:  2006-08       Impact factor: 10.047

5.  International survey of patients with von Willebrand disease and angiodysplasia.

Authors:  E Fressinaud; D Meyer
Journal:  Thromb Haemost       Date:  1993-09-01       Impact factor: 5.249

6.  Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.

Authors:  Ulrich Budde; Antje Pieconka; Kirsten Will; Reinhard Schneppenheim
Journal:  Semin Thromb Hemost       Date:  2006-07       Impact factor: 4.180

7.  Laboratory tests for measurement of von Willebrand factor show poor agreement among different centers: results from the United Kingdom National External Quality Assessment Scheme for Blood Coagulation.

Authors:  Steve Kitchen; Ion Jennings; Tim A L Woods; Dianne P Kitchen; Isobel D Walker; Francis E Preston
Journal:  Semin Thromb Hemost       Date:  2006-07       Impact factor: 4.180

8.  Acquired von Willebrand syndrome in aortic stenosis.

Authors:  André Vincentelli; Sophie Susen; Thierry Le Tourneau; Isabelle Six; Olivier Fabre; Francis Juthier; Anne Bauters; Christophe Decoene; Jenny Goudemand; Alain Prat; Brigitte Jude
Journal:  N Engl J Med       Date:  2003-07-24       Impact factor: 91.245

9.  A highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF:RCo) activity assay by flow cytometry.

Authors:  D Chen; C A Daigh; J I Hendricksen; R K Pruthi; W L Nichols; J A Heit; W G Owen
Journal:  J Thromb Haemost       Date:  2007-11-20       Impact factor: 5.824

10.  von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA).

Authors:  W L Nichols; M B Hultin; A H James; M J Manco-Johnson; R R Montgomery; T L Ortel; M E Rick; J E Sadler; M Weinstein; B P Yawn
Journal:  Haemophilia       Date:  2008-03       Impact factor: 4.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.